Researchers discuss what we know about the protein alpha-synuclein that clumps in the brain cells of all people with Parkinson's and how scientists are designing drugs against this therapeutic target.
Researchers discuss what we know about the protein alpha-synuclein that clumps in the brain cells of all people with Parkinson's and how scientists are designing drugs against this therapeutic target.